Effectiveness of Mitragynine Topical Patch for Pain Reduction in Myofascial Pain Syndrome
- NCT ID
- NCT07713771
- Registry status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Sponsor
- Prince of Songkla University
- Conditions
- Myofascial Pain Syndrome - Neck, Topical Analgesia
Overview
ClinicalTrials.gov lists this study as Not yet recruiting.
Official title: Effectiveness of Mitragynine Topical Patch From Kratom for Pain Reduction in Myofascial Pain Syndrome of Upper Trapezius Muscle: Double Blinded Placebo, Randomized Controlled Trial
Enrollment: 64 participants (Estimated).
What is being studied
- Drug: mitragynine topical patch from kratom
- Drug: Placebo
Who may be eligible
- Ages
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: Thailand
- Changwat Songkhla, Thailand: 1
Sample of listed locations
- Prince of Songkla university — Songkhla, Changwat Songkhla, 90110, Thailand — Site recruitment status not specified in the registry data
Study details
- Start date
- October 1, 2026
- Primary completion date
- October 31, 2028
- Completion date
- October 31, 2029
- First posted
- July 20, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07713771
- Registry last updated
- August 10, 2026
- QualifiedStudies registry data refreshed
- October 5, 2026
- QualifiedStudies record fetched
- October 5, 2026
View NCT07713771 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Neck Pain studies | Clinical trial FAQ